00Analysts expect a dividend of 2.69 CHF per share. Thus the dividend yield equals 7.19 percent. The average dividend yield of the biotech companies equals an attractive 3.55 percent.
Tomorrow the Swiss BB Biotech will publish its past quarters figures. Over the current book year the company from Schaffhausen's total revenue could be around 124.5 million CHF (consensus estimates). This is hugely more than 2023's revenue of 0.53 million CHF.
The analysts expect for 2024 a net profit of 203 million CHF. For this year the consensus of BB Biotech 's result per share is a profit of 3.73 CHF. The price-earnings-ratio equals 10.03.
BB Biotech 's market capitalization is based on the number of outstanding shares around 2.05 billion CHF.
On Wednesday the stock closed at 37.4 CHF.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.